KOLs Interview Series: Dr. Charles Cantor @InsilicoMedicine
KOLs Interview Series: Dr. Charles Cantor  @InsilicoMedicine
Uploaded February 2021 | Updated September 2026, 1 week ago
To read more about the discovery: insilico.com/blog/pcc

Dr. Charles Cantor
Professor Emeritus at Boston University, Co-Founder of Sequenom Inc.,
Co-Founder of Retrotope Inc.
Former Principal Scientist of Human Genome Project, Department of Energy,
Co-founder of Sequenom (acquired by LabCorp), Professor and Director
of the Center for Advanced Biotechnology, Boston University
KOLs Interview Series: Dr. Charles CantorCGTN Live with Alex ZhavoronkovPandaOmics 3.0 - the tool for OMICS Data Analysis, Pathway Analysis and Visualization, and Target IDAI-Unleashed - Docuthon Honorable MentionStory of Rentosertib ISM001-055ARDD is about to start - things to knowKOLs Interview Series: Dr. Yuri NikolskyGrand Opening of Insilico Medicines Generative AI and Quantum Computing R&D Center in Abu DhabiInsilico Medicines AI-Powered Robotics LabTour Insilico Medicines AI-Powered Robotics LabPaper Decoding | Finding dual-purpose targets for aging and disease using PandaOmicsInClinico - a platform for clinical leaders to assess trial risk and aid in portfolio triage.
Insilico Medicine |

KOLs' Interview Series: Dr. Charles Cantor

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER